SCHEMBL8065945

SCHEMBL8065945

O=C(/C=C/c1cccc([N+](=O)[O-])c1)Nc1cccc(C(=O)O)c1

nearest known ligand 0.84

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.84
KMT2A Q03164 7/20 0.84
ALDH1A1 P00352 5/20 0.84
SMN1; SMN2 Q16637 4/20 0.84
MAPT P10636 6/20 0.78
CYP1A2 P05177 1/20 0.78
CYP3A4 P08684 1/20 0.78
CYP2C19 P33261 1/20 0.78
RAB9A P51151 1/20 0.78
TRPV1 Q8NER1 6/20 0.73
LMNA P02545 3/20 0.64
HPGD P15428 1/20 0.64
HTT P42858 2/20 0.64
RECQL P46063 1/20 0.64
POLB P06746 1/20 0.64
MAPK1 P28482 2/20 0.62
MAOB P27338 1/20 0.62
LTB4R Q15722 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8065947 1.00 MEN1 (0.84) MEN1KMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL8063754 0.89 KMT2A (0.77) MEN1KMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL8063757 0.89 KMT2A (0.77) MEN1KMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL23547197 0.86 TRPV1 (0.73) MEN1KMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL6754378 0.86 TRPV1 (0.73) MEN1KMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL6754380 0.86 TRPV1 (0.73) MEN1KMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL15176833 0.84 TRPV1 (1.00) MEN1KMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL8049032 0.83 LTB4R (0.84) MEN1KMT2ASMN1; SMN2MAPTRAB9A
SCHEMBL8049033 0.83 LTB4R (0.84) MEN1KMT2ASMN1; SMN2MAPTRAB9A
SCHEMBL8061631 0.82 MEN1 (0.71) MEN1KMT2AALDH1A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127392-A A MUSCLE RELAXANT FOR TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION; INOTROPIC AGENT AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-03 US disclosed
US-6046239-A USED IN THE TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION, VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION SUCH AS URINARY INCONTINENCE, ASTHMA, ANGINA, PREMATURE LABOR, CONGESTIVE HEART FAILURE AMERICAN HOME PRODUCTS CORPORATION (US) 2000-04-04 US disclosed